Cabaletta Bio, Inc.
NASDAQ:CABA · NASDAQ Global Select
+$0.04 today
Vol 17.18M · Avg 3.33M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+62.29%
Period High
$4.15
Period Low
$1.33
Latest
$2.84
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.29B
Allogene Therapeutics, Inc.
NASDAQ:ALLO
$484.64M
Lexeo Therapeutics, Inc. Common Stock
NASDAQ:LXEO
$389.07M
Kyverna Therapeutics, Inc.
NASDAQ:KYTX
$349.90M
Atea Pharmaceuticals, Inc.
NASDAQ:AVIR
$345.72M
Lyell Immunopharma, Inc.
NASDAQ:LYEL
$297.21M
Editas Medicine, Inc.
NASDAQ:EDIT
$252.09M
ProQR Therapeutics N.V.
NASDAQ:PRQR
$194.64M
Humacyte, Inc.
NASDAQ:HUMA
$154.49M
Immutep Limited
NASDAQ:IMMP
$55.41M
What is the latest CABA filing?
The latest filing shown is 8-K dated Jun 11, 2026.
How many recent filings does CABA have?
Intrinsic Alpha currently shows 20 recent filings for CABA.
Explore More
Continue the stock analysis
Jump to another research area for this company.